$PBH
Prestige Consumer Healthcare Inc

2019 Q2 Form 10-Q Financial Statement

#000129594719000023 Filed on August 01, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $232.2M $254.0M
YoY Change -8.59% -1.01%
Cost Of Revenue $98.09M $113.4M
YoY Change -13.47% 0.23%
Gross Profit $134.1M $140.6M
YoY Change -4.66% -1.99%
Gross Profit Margin 57.75% 55.37%
Selling, General & Admin $56.50M $61.10M
YoY Change -7.53% 6.63%
% of Gross Profit 42.14% 43.45%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.061M $8.372M
YoY Change -15.66% -1.59%
% of Gross Profit 5.27% 5.95%
Operating Expenses $62.58M $68.14M
YoY Change -8.15% 5.6%
Operating Profit $71.49M $72.49M
YoY Change -1.38% -8.19%
Interest Expense -$25.00M -$25.90M
YoY Change -3.47% -1.52%
% of Operating Profit -34.97% -35.73%
Other Income/Expense, Net -$416.0K -$87.00K
YoY Change 378.16% -217.57%
Pretax Income $46.05M $46.46M
YoY Change -0.88% -11.82%
Income Tax $12.13M $11.99M
% Of Pretax Income 26.33% 25.82%
Net Earnings $33.93M $34.47M
YoY Change -1.57% 2.09%
Net Earnings / Revenue 14.61% 13.57%
Basic Earnings Per Share $0.66 $0.65
Diluted Earnings Per Share $0.65 $0.65
COMMON SHARES
Basic Shares Outstanding 51.70M shares 52.64M shares
Diluted Shares Outstanding 52.05M shares 52.94M shares

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.00M $34.30M
YoY Change -15.45% -22.22%
Cash & Equivalents $29.04M $34.27M
Short-Term Investments
Other Short-Term Assets $9.200M $10.90M
YoY Change -15.6% -64.5%
Inventory $129.4M $116.8M
Prepaid Expenses
Receivables $142.9M $146.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $310.5M $314.5M
YoY Change -1.26% -4.19%
LONG-TERM ASSETS
Property, Plant & Equipment $51.39M $52.45M
YoY Change -2.03% 3.93%
Goodwill $578.3M $613.0M
YoY Change -5.65% -0.4%
Intangibles $2.501B $2.723B
YoY Change -8.12% -6.06%
Long-Term Investments
YoY Change
Other Assets $3.038M $3.415M
YoY Change -11.04% -52.19%
Total Long-Term Assets $3.150B $3.454B
YoY Change -8.8% -3.28%
TOTAL ASSETS
Total Short-Term Assets $310.5M $314.5M
Total Long-Term Assets $3.150B $3.454B
Total Assets $3.461B $3.769B
YoY Change -8.17% -3.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.11M $78.41M
YoY Change -20.78% 24.97%
Accrued Expenses $75.70M $63.80M
YoY Change 18.65% -11.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $143.5M $142.3M
YoY Change 0.87% -7.39%
LONG-TERM LIABILITIES
Long-Term Debt $1.779B $1.994B
YoY Change -10.75% -7.07%
Other Long-Term Liabilities $19.94M $23.08M
YoY Change -13.6% 32.31%
Total Long-Term Liabilities $1.799B $2.017B
YoY Change -10.79% -6.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $143.5M $142.3M
Total Long-Term Liabilities $1.799B $2.017B
Total Liabilities $2.359B $2.607B
YoY Change -9.51% -14.27%
SHAREHOLDERS EQUITY
Retained Earnings $735.7M $737.6M
YoY Change -0.25% 71.35%
Common Stock $537.0K $536.0K
YoY Change 0.19% 0.56%
Preferred Stock
YoY Change
Treasury Stock (at cost) $89.49M $59.93M
YoY Change 49.33% 686.35%
Treasury Stock Shares 2.848M shares 1.871M shares
Shareholders Equity $1.102B $1.162B
YoY Change
Total Liabilities & Shareholders Equity $3.461B $3.769B
YoY Change -8.17% -3.36%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $33.93M $34.47M
YoY Change -1.57% 2.09%
Depreciation, Depletion And Amortization $7.061M $8.372M
YoY Change -15.66% -1.59%
Cash From Operating Activities $52.78M $55.85M
YoY Change -5.51% 3.2%
INVESTING ACTIVITIES
Capital Expenditures $1.956M $2.469M
YoY Change -20.78% -3.33%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.956M -$2.469M
YoY Change -20.78% 55.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $28.77M $49.98M
YoY Change -42.44%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$49.29M -$51.38M
YoY Change -4.07% 1.55%
NET CHANGE
Cash From Operating Activities $52.78M $55.85M
Cash From Investing Activities -$1.956M -$2.469M
Cash From Financing Activities -$49.29M -$51.38M
Net Change In Cash $1.512M $1.721M
YoY Change -12.14% -11.43%
FREE CASH FLOW
Cash From Operating Activities $52.78M $55.85M
Capital Expenditures $1.956M $2.469M
Free Cash Flow $50.82M $53.38M
YoY Change -4.8% 3.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2019Q2 dei Amendment Flag
AmendmentFlag
false
CY2019Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2019Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001295947
CY2014Q2 pbh Sharebased Compensation Arrangementby Sharebased Payment Award Extensionof Expiration Period
SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod
P10Y
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12965000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12059000 USD
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53670000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53741000 shares
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
19600000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
19600000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
19600000 USD
CY2019Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
20500000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y2M27D
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2019Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1871000 shares
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2848000 shares
CY2019Q2 dei Document Type
DocumentType
10-Q
CY2019Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2019Q2 dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
CY2019Q2 dei Entity File Number
EntityFileNumber
001-32433
CY2019Q2 dei Entity Registrant Name
EntityRegistrantName
PRESTIGE CONSUMER HEALTHCARE INC.
CY2019Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1297589
CY2019Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
660 White Plains Road
CY2019Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
CY2019Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2019Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591
CY2019Q2 dei City Area Code
CityAreaCode
914
CY2019Q2 dei Local Phone Number
LocalPhoneNumber
524-6800
CY2019Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2019Q2 dei Trading Symbol
TradingSymbol
PBH
CY2019Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q2 dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50241294 shares
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2018Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
112069000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253980000 USD
CY2019Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
97100000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
987000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1288000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
98087000 USD
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
113357000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
134067000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
140623000 USD
CY2019Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
34801000 USD
CY2018Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
37111000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21706000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23941000 USD
CY2019Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6074000 USD
CY2018Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7084000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
62581000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
68136000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
71486000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
72487000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
43000 USD
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000 USD
CY2019Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
25063000 USD
CY2018Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
26040000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-416000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87000 USD
CY2019Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-25436000 USD
CY2018Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-26027000 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
46050000 USD
CY2018Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
46460000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12125000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11994000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
34466000 USD
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51697000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52640000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52047000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52942000 shares
CY2019Q2 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
-224000 USD
CY2018Q2 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease
-2974000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33701000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31492000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29042000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27530000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
142927000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-224000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2974000 USD
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
148787000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
129388000 USD
CY2019Q1 us-gaap Inventory Net
InventoryNet
119880000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9164000 USD
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4741000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
310521000 USD
CY2019Q1 us-gaap Assets Current
AssetsCurrent
300938000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51387000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51176000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16097000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Goodwill
Goodwill
578309000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
578583000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2501358000 USD
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2507210000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3038000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3129000 USD
CY2019Q2 us-gaap Assets
Assets
3460710000 USD
CY2019Q1 us-gaap Assets
Assets
3441036000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
62109000 USD
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
56560000 USD
CY2019Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
13937000 USD
CY2019Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
9756000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5099000 USD
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
62346000 USD
CY2019Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
60663000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
143491000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
126979000 USD
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1779380000 USD
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1798598000 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
403750000 USD
CY2019Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
399575000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12526000 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19940000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20053000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
2359087000 USD
CY2019Q1 us-gaap Liabilities
Liabilities
2345205000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
537000 USD
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
536000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
480805000 USD
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
479150000 USD
CY2018Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9303000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4335000 USD
CY2018Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
52259000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
34466000 USD
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
89493000 USD
CY2019Q1 us-gaap Treasury Stock Value
TreasuryStockValue
59928000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25971000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25747000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
735745000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
880000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
701820000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1101623000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1095831000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3460710000 USD
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3441036000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1095831000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1381000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
275000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
29565000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-224000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1101623000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
1178610000 USD
CY2019Q2 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
1343000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1657000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2974000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
1161723000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
34466000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7061000 USD
CY2018Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8372000 USD
CY2019Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-20000 USD
CY2018Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000 USD
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4206000 USD
CY2018Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6755000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
851000 USD
CY2018Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
920000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1381000 USD
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1657000 USD
CY2019Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
1338000 USD
CY2018Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-623000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5306000 USD
CY2018Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
0 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5808000 USD
CY2018Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4357000 USD
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8939000 USD
CY2019Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49290000 USD
CY2018Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-51379000 USD
CY2019Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28766000 USD
CY2018Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
49978000 USD
CY2018Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16479000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1956000 USD
CY2018Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2469000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7616000 USD
CY2018Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
347000 USD
CY2019Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
-1368000 USD
CY2018Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
0 USD
CY2019Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
93000 USD
CY2018Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
108000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52777000 USD
CY2018Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55852000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1956000 USD
CY2018Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2469000 USD
CY2018Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
20000000 USD
CY2019Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35000000 USD
CY2018Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
275000 USD
CY2018Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
880000 USD
CY2019Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
799000 USD
CY2018Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2281000 USD
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-19000 USD
CY2018Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-283000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1512000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1721000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27530000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32548000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29042000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34269000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
19966000 USD
CY2018Q2 us-gaap Interest Paid Net
InterestPaidNet
20907000 USD
CY2019Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1807000 USD
CY2018Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
334000 USD
CY2019Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.  Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.  </span></div>
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17435000 USD
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5697000 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13296000 USD
CY2019Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
60663000 USD
CY2019Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
59105000 USD
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
342000 USD
CY2019Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
14367000 USD
CY2019Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
17082000 USD
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
161000 USD
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
114679000 USD
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
102637000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
129388000 USD
CY2019Q1 us-gaap Inventory Net
InventoryNet
119880000 USD
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5600000 USD
CY2019Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5500000 USD
CY2019Q1 us-gaap Goodwill Gross
GoodwillGross
742294000 USD
CY2019Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
163711000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
578583000 USD
CY2019Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
274000 USD
CY2019Q2 us-gaap Goodwill Gross
GoodwillGross
742020000 USD
CY2019Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
163711000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
578309000 USD
CY2019Q1 pbh Intangible Assets Gross
IntangibleAssetsGross
2663474000 USD
CY2019Q2 pbh Intangible Assets Translation Adjustments Gain Loss
IntangibleAssetsTranslationAdjustmentsGainLoss
960000 USD
CY2019Q2 pbh Intangible Assets Gross
IntangibleAssetsGross
2662514000 USD
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
156264000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4906000 USD
CY2019Q2 pbh Finite Lived Intangible Assets Accumulated Amortization Translation Adjustments Gain Loss
FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
14000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
161156000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2501358000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 USD
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5800000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
14700000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
19600000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
135900000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1216000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
16599000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
914000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
16924000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4577000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3450000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2488000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1794000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1705000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
6761000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20775000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3150000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
17625000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0521
CY2019Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
62346000 USD
CY2019Q2 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
9252000 USD
CY2019Q1 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
6788000 USD
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3142000 USD
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2881000 USD
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2478000 USD
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1789000 USD
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1705000 USD
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
6780000 USD
CY2019Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
18775000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20500000 USD
CY2019Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
31886000 USD
CY2019Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
31228000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5701000 USD
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10958000 USD
CY2019Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1057000 USD
CY2019Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1361000 USD
CY2019Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5640000 USD
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
88000 USD
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2284000 USD
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2441000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6526000 USD
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7799000 USD
CY2019Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
60663000 USD
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1793000000 USD
CY2019Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1813000000 USD
CY2019Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
13620000 USD
CY2019Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
14402000 USD
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
1779380000 USD
CY2019Q1 us-gaap Long Term Debt
LongTermDebt
1798598000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
455000000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1338000000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
0 USD
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1793000000 USD
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000.0 shares
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 pbh Voting Rights Number Of Votes Per Common Share Owned
VotingRightsNumberOfVotesPerCommonShareOwned
1 vote
CY2019Q2 us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2019Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
949825 shares
CY2018Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1449750 shares
CY2019Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
30.29
CY2018Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
34.47
CY2019Q2 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2018Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
900000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
34466000 USD
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51697000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52640000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
350000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
302000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52047000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52942000 shares
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
1000000.0 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
2500000 shares
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1400000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1700000 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
200000 USD
CY2018Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
200000 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11000000.0 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2019Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
6100000 USD
CY2018Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
10700000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
300000 USD
CY2019Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
400000 USD
CY2018Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
1200000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1400000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
29.46
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
95900 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
42.62
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4054000 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
873200 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.83
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.22
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
41.79
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
294500 shares
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
29.46
CY2018Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
32800 shares
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
26.81
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
72700 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
45.00
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1062200 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.61
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6573000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
599800 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
37.99
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
944600 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.45
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
302700 shares
CY2019Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.53
CY2019Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9300 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1142100 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
36.07
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2540000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
628600 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
38.70
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2206000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258
CY2019Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
577000 USD
CY2018Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
610000 USD
CY2019Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
721000 USD
CY2018Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
768000 USD
CY2019Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-144000 USD
CY2018Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-158000 USD
CY2019Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
113 manufacturer
CY2018Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
116 manufacturer
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
98087000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
134067000 USD
CY2019Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
34801000 USD
CY2019Q2 pbh Contribution Margin
ContributionMargin
99266000 USD
CY2019Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
27780000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
71486000 USD
CY2019Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-25436000 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
46050000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12125000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253980000 USD
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
113357000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
140623000 USD
CY2018Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
37111000 USD
CY2018Q2 pbh Contribution Margin
ContributionMargin
103512000 USD
CY2018Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
31025000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
72487000 USD
CY2018Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-26027000 USD
CY2018Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
46460000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11994000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
34466000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253980000 USD
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2507210000 USD
CY2019Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3085793000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253980000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
578309000 USD
CY2019Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2272294000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
229064000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2501358000 USD
CY2019Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3079667000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
578583000 USD
CY2019Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2273191000 USD
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
234019000 USD

Files In Submission

Name View Source Status
0001295947-19-000023-index-headers.html Edgar Link pending
0001295947-19-000023-index.html Edgar Link pending
0001295947-19-000023.txt Edgar Link pending
0001295947-19-000023-xbrl.zip Edgar Link pending
exhibit101geodisredacted.htm Edgar Link pending
exhibit101geodisredacted001.jpg Edgar Link pending
exhibit101geodisredacted002.jpg Edgar Link pending
exhibit101geodisredacted003.jpg Edgar Link pending
exhibit101geodisredacted004.jpg Edgar Link pending
exhibit101geodisredacted005.jpg Edgar Link pending
exhibit101geodisredacted006.jpg Edgar Link pending
exhibit101geodisredacted007.jpg Edgar Link pending
exhibit101geodisredacted008.jpg Edgar Link pending
exhibit101geodisredacted009.jpg Edgar Link pending
exhibit101geodisredacted010.jpg Edgar Link pending
exhibit101geodisredacted011.jpg Edgar Link pending
exhibit101geodisredacted012.jpg Edgar Link pending
exhibit101geodisredacted013.jpg Edgar Link pending
exhibit101geodisredacted014.jpg Edgar Link pending
exhibit101geodisredacted015.jpg Edgar Link pending
exhibit101geodisredacted016.jpg Edgar Link pending
exhibit101geodisredacted017.jpg Edgar Link pending
exhibit101geodisredacted018.jpg Edgar Link pending
exhibit101geodisredacted019.jpg Edgar Link pending
exhibit101geodisredacted020.jpg Edgar Link pending
exhibit101geodisredacted021.jpg Edgar Link pending
exhibit101geodisredacted022.jpg Edgar Link pending
exhibit101geodisredacted023.jpg Edgar Link pending
exhibit101geodisredacted024.jpg Edgar Link pending
exhibit101geodisredacted025.jpg Edgar Link pending
exhibit101geodisredacted026.jpg Edgar Link pending
exhibit101geodisredacted027.jpg Edgar Link pending
exhibit101geodisredacted028.jpg Edgar Link pending
exhibit101geodisredacted029.jpg Edgar Link pending
exhibit101geodisredacted030.jpg Edgar Link pending
exhibit101geodisredacted031.jpg Edgar Link pending
exhibit101geodisredacted032.jpg Edgar Link pending
exhibit101geodisredacted033.jpg Edgar Link pending
exhibit101geodisredacted034.jpg Edgar Link pending
exhibit101geodisredacted035.jpg Edgar Link pending
exhibit101geodisredacted036.jpg Edgar Link pending
exhibit101geodisredacted037.jpg Edgar Link pending
exhibit101geodisredacted038.jpg Edgar Link pending
exhibit101geodisredacted039.jpg Edgar Link pending
exhibit101geodisredacted040.jpg Edgar Link pending
exhibit101geodisredacted041.jpg Edgar Link pending
exhibit101geodisredacted042.jpg Edgar Link pending
exhibit101geodisredacted043.jpg Edgar Link pending
exhibit101geodisredacted044.jpg Edgar Link pending
exhibit101geodisredacted045.jpg Edgar Link pending
exhibit101geodisredacted046.jpg Edgar Link pending
exhibit101geodisredacted047.jpg Edgar Link pending
exhibit101geodisredacted048.jpg Edgar Link pending
exhibit101geodisredacted049.jpg Edgar Link pending
exhibit101geodisredacted050.jpg Edgar Link pending
exhibit101geodisredacted051.jpg Edgar Link pending
exhibit101geodisredacted052.jpg Edgar Link pending
exhibit101geodisredacted053.jpg Edgar Link pending
exhibit101geodisredacted054.jpg Edgar Link pending
exhibit101geodisredacted055.jpg Edgar Link pending
exhibit101geodisredacted056.jpg Edgar Link pending
exhibit101geodisredacted057.jpg Edgar Link pending
exhibit101geodisredacted058.jpg Edgar Link pending
exhibit101geodisredacted059.jpg Edgar Link pending
exhibit101geodisredacted060.jpg Edgar Link pending
exhibit101geodisredacted061.jpg Edgar Link pending
exhibit101geodisredacted062.jpg Edgar Link pending
exhibit101geodisredacted063.jpg Edgar Link pending
exhibit101geodisredacted064.jpg Edgar Link pending
exhibit101geodisredacted065.jpg Edgar Link pending
exhibit101geodisredacted066.jpg Edgar Link pending
exhibit101geodisredacted067.jpg Edgar Link pending
exhibit101geodisredacted068.jpg Edgar Link pending
exhibit3112019-06x30.htm Edgar Link pending
exhibit3122019-06x30.htm Edgar Link pending
exhibit3212019-06x30.htm Edgar Link pending
exhibit3222019-06x30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pbh-20190630.xsd Edgar Link pending
pbh-20190630_cal.xml Edgar Link unprocessable
pbh-20190630_def.xml Edgar Link unprocessable
pbh-20190630_lab.xml Edgar Link unprocessable
pbh-20190630_pre.xml Edgar Link unprocessable
pbh10qjune302019.htm Edgar Link pending
pbh10qjune302019_htm.xml Edgar Link completed
pch01.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending